Tag: venous thromboembolism
Mitchell Silver joins Contego Medical as chief medical officer
Contego Medical recently announced that Mitchell Silver, an interventional cardiologist and vascular medicine specialist, has joined the team as chief medical officer (CMO).
A press...
Innova Vascular announces successful early commercial use of Laguna thrombectomy system...
Innova Vascular has announced successful early commercial use of the company's Laguna thrombectomy system. Physicians at UCLA Medical Center in Los Angeles, USA, and...
The pulmonary arterial tree—it is time we branch out
Nicolas J Mouawad (McLaren Health System, Bay City, USA) urges vascular surgeons to “get out of their comfort zone” and become more involved in...
Vascular News’ top 10 most popular stories of February 2023
February's top 10 includes the announcement that Abbott is to acquire Cardiovascular Systems, results of the PRESERVE study on the safety and effectiveness of...
New study demonstrates IVC filters “safe and effective” in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Arteriovenous graft use linked to venous thromboembolism risk in haemodialysis patients
In an observational cohort study of Medicare beneficiaries receiving haemodialysis, the use of an arteriovenous graft (AVG) compared with an arteriovenous fistula (AVF) was...
Michael Cerminaro to succeed Marvin Woodall as CEO of Thrombolex
Thrombolex has announced that its board of directors has named Michael Cerminaro chief executive officer (CEO) effective 13 July 2022, the date of the...
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Prolonged TV watching may increase risk of venous thromboembolism
A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...
BTG acquires Novate Medical
BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...
First patient enrolled in Daiichi Sankyo European edoxaban registry
The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...
